RDAF hosts multi-stakeholder workshop on post-marketing registries

    13 Jul, 2023

    The Rare Disease Action Forum (RDAF) will host a multi-stakeholder workshop on post-marketing registries for rare diseases on 21 September 2023 (14.00 – 19.00 CEST) in Basel, Switzerland.

    The workshop will gather stakeholders active in the rare disease field to discuss the set up and management of post-marketing registries for orphan drugs.

    The event aims to:

    • Exchange experiences on the set-up and management of registries in Switzerland and neighboring countries
    • Define an actionable framework for the creation and management of post-marketing registries for rare diseases in Switzerland

    The workshop will be held in German.

    The event will be followed by a networking apéro, to enable participants to continue the discussions and meet other actors from the Swiss rare disease community.

    Please register here.

    Continue reading

    Boehringer Ingelheim joins the Rare Disease Action Forum

    We are delighted to announce Boehringer Ingelheim as new member of the Rare Disease Action Forum. Boehringer Ingelheim’s membership fortifies RDAF's multi-stakeholder base, alongside other members from industry, patient organizations, healthcare professionals, and...